The Swiss bank has issued 360 structured products in the US market during the third quarter of 2021 valuing US$1.2 billion, compared with 480 products totalling US$1.6 billion in the same period a year prior.
The bank’s activity was inconsistent in 2021 with sales slipping to US$1.4 billion (442 products) in the fourth quarter of 2020 and subsequently increasing by 6% in Q1 21. The second quarter of 2021 saw a steep decline in structured product activity with sales standing at US$697m (221 products) at the end of the quarter. However, Credit Suisse’s Q3 21 sales volumes signal a 72% jump from the previous quarterly period despite a drop in product issuance (360 products/US$1.2 bill
Continue reading and get unlimited access for 7 days with a free trial of SRP.
Get a free trialAlready a subscriber? Login